Clinical Trial Update: Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating adjuvant chemotherapy after postenucleation surgery in high-risk retinoblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinoblastoma | Phase 3 | Status: RECRUITING